Marshall S. Stanton, SVP, Clinical & MD Affair at ARTIVION, INC. (AORT), sold 51,011 shares at $28.46 ($1.5M) on 2025-06-13, disclosed to the SEC on 2025-06-16.
Scheduled sale ($1.5M) by SVP, Clinical & MD Affair under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.42 | 14,306 | $407K | 28.0% |
| 2 | $28.42 | 14,306 | $407K | 28.0% |
| 3 | $28.43 | 1,826 | $52K | 3.6% |
| 4 | $28.43 | 1,826 | $52K | 3.6% |
| 5 | $28.46 | 8,747 | $249K | 17.2% |
| 6 | $28.46 | 8,747 |
| $249K |
| 17.2% |
| 7 | $28.47 | 1,253 | $36K | 2.5% |
| Total | $28.44 avg | 51,011 | $1.5M | 100% |
| Filing → |
| AORT | SELL | 2026-02-25 | $136K | — | Filing → |
| AORT | SELL | 2025-11-24 | $1.3M | — | Filing → |
| AORT | SELL | 2025-11-24 | $4.3M | — | Filing → |